{"title":"The Impact of Electronic Prescribing System Factors on Prescribing Decision Making: A Systematic Review and Narrative Synthesis","authors":"N. Alaboud, Y. Jani, B. D. Franklin","doi":"10.1093/ijpp/riad074.003","DOIUrl":null,"url":null,"abstract":"Medication prescribing is a complex and error-prone process in clinical practice1. Using electronic prescribing systems (EP) allow healthcare providers to prescribe medications electronically. However, many factors can affect the implementation and utilisation of EP systems, including factors related to the end-users, system, and organization2. This systematic review aimed to explore and synthesise the literature on the impact of EP system factors on prescribing decision-making. Objectives were to: map the current evidence for EP system factors that inhibit or facilitate prescribing decision-making; identify the positive and negative impact of different design features or data integration of EP systems on prescribing decision-making; identify evidence on the most effective ways to display patient-specific data to aid prescribers in making their prescribing decisions; and make recommendations for future clinical practice and research in designing EP systems. We searched PubMed, Medline, Embase and the Cumulative Index to Nursing Allied Health Literature databases for studies published from January 2000 to February 2023 We included all types of primary studies (both evaluative and descriptive study designs) that explored the effect of EP system factors on prescribing decision-making in any healthcare setting. Methodological quality was assessed using the Mixed Methods Appraisal Tool (MMAT)3. Emergent themes were identified and subjected to narrative synthesis. The protocol was registered with PROSPERO (registration: CRD42021235988). Searches identified 6752; after deduplication, 4925 articles underwent title and abstract screening, and 227 underwent full-text review, of which 54 were included from 13 different countries. There were a range of study designs; most (n=30) adopted quantitative methods such as retrospective evaluation by extracting the data from an EP system, nine adopted qualitative approaches such as interviews, and a further 15 used mixed methods. According to MMAT, 32 of 54 studies were deemed to be of high quality. Based on the findings of included studies, three key EP system factors were derived that could affect medication-related decision-making during prescribing processes: (1) design features of CDSS within EP system (how the EP system design interact with the prescriber at the point of prescribing and which design feature has been used), (2) displayed information at the point of prescribing (what and how data displayed to the prescriber at point of prescribing) and (3) Type of EP system based on the system developer (a commercial vs. a homegrown EP system). A total of 18 EP system factors were found that have either positive or negative effects on influencing prescribers’ decision-making and prescribing workflow. The end-users of the EP system played essential roles in system acceptance, and its success in real practices. However, there is a need for more consensus within the literature on designing, implementing, and evaluating EP systems regarding how and when to evaluate any new modifications within the system. Future research should explore the different used design strategies which result in a positive impact on prescribing decision-making and learn from those that have not been successful to develop guidelines/standards for designing EP systems. 1. Samadbeik, M., M. Ahmadi, and S.M. Hosseini Asanjan, A theoretical approach to electronic prescription system: lesson learned from literature review. Iran Red Crescent Med J, 2013. 15(10): p. e8436. 2. Sweidan, M., et al., Identification of features of electronic prescribing systems to support quality and safety in primary care using a modified Delphi process. BMC Med Inform Decis Mak, 2010. 10: p. 21. 3. Hong, Q.N., et al., The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Education for information, 2018. 34(4): p. 285-291.","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmacy Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ijpp/riad074.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Medication prescribing is a complex and error-prone process in clinical practice1. Using electronic prescribing systems (EP) allow healthcare providers to prescribe medications electronically. However, many factors can affect the implementation and utilisation of EP systems, including factors related to the end-users, system, and organization2. This systematic review aimed to explore and synthesise the literature on the impact of EP system factors on prescribing decision-making. Objectives were to: map the current evidence for EP system factors that inhibit or facilitate prescribing decision-making; identify the positive and negative impact of different design features or data integration of EP systems on prescribing decision-making; identify evidence on the most effective ways to display patient-specific data to aid prescribers in making their prescribing decisions; and make recommendations for future clinical practice and research in designing EP systems. We searched PubMed, Medline, Embase and the Cumulative Index to Nursing Allied Health Literature databases for studies published from January 2000 to February 2023 We included all types of primary studies (both evaluative and descriptive study designs) that explored the effect of EP system factors on prescribing decision-making in any healthcare setting. Methodological quality was assessed using the Mixed Methods Appraisal Tool (MMAT)3. Emergent themes were identified and subjected to narrative synthesis. The protocol was registered with PROSPERO (registration: CRD42021235988). Searches identified 6752; after deduplication, 4925 articles underwent title and abstract screening, and 227 underwent full-text review, of which 54 were included from 13 different countries. There were a range of study designs; most (n=30) adopted quantitative methods such as retrospective evaluation by extracting the data from an EP system, nine adopted qualitative approaches such as interviews, and a further 15 used mixed methods. According to MMAT, 32 of 54 studies were deemed to be of high quality. Based on the findings of included studies, three key EP system factors were derived that could affect medication-related decision-making during prescribing processes: (1) design features of CDSS within EP system (how the EP system design interact with the prescriber at the point of prescribing and which design feature has been used), (2) displayed information at the point of prescribing (what and how data displayed to the prescriber at point of prescribing) and (3) Type of EP system based on the system developer (a commercial vs. a homegrown EP system). A total of 18 EP system factors were found that have either positive or negative effects on influencing prescribers’ decision-making and prescribing workflow. The end-users of the EP system played essential roles in system acceptance, and its success in real practices. However, there is a need for more consensus within the literature on designing, implementing, and evaluating EP systems regarding how and when to evaluate any new modifications within the system. Future research should explore the different used design strategies which result in a positive impact on prescribing decision-making and learn from those that have not been successful to develop guidelines/standards for designing EP systems. 1. Samadbeik, M., M. Ahmadi, and S.M. Hosseini Asanjan, A theoretical approach to electronic prescription system: lesson learned from literature review. Iran Red Crescent Med J, 2013. 15(10): p. e8436. 2. Sweidan, M., et al., Identification of features of electronic prescribing systems to support quality and safety in primary care using a modified Delphi process. BMC Med Inform Decis Mak, 2010. 10: p. 21. 3. Hong, Q.N., et al., The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Education for information, 2018. 34(4): p. 285-291.
在临床实践中,药物处方是一个复杂且容易出错的过程1。使用电子处方系统(EP)可让医疗服务提供者以电子方式开具处方。然而,许多因素会影响电子处方系统的实施和使用,包括与最终用户、系统和组织相关的因素2。 本系统综述旨在探讨和综合有关 EP 系统因素对处方决策影响的文献。目的是:梳理目前有关电子病历系统抑制或促进处方决策的因素的证据;确定电子病历系统的不同设计特点或数据整合对处方决策的积极和消极影响;确定有关显示患者特定数据的最有效方法的证据,以帮助处方者做出处方决策;并对未来的临床实践和电子病历系统设计研究提出建议。 我们检索了 PubMed、Medline、Embase 和 Cumulative Index to Nursing Allied Health Literature 数据库中 2000 年 1 月至 2023 年 2 月期间发表的研究。我们纳入了探讨 EP 系统因素对任何医疗机构处方决策影响的所有类型的主要研究(包括评价性和描述性研究设计)。我们使用混合方法评估工具(MMAT)3 对方法学质量进行了评估,确定了新出现的主题,并对其进行了叙事综合。研究方案已在 PROSPERO 注册(注册号:CRD42021235988)。 搜索共发现了 6752 篇文章;经过重复筛选后,有 4925 篇文章通过了标题和摘要筛选,227 篇文章通过了全文审阅,其中 54 篇文章来自 13 个不同的国家。研究设计多种多样;大多数(n=30)采用了定量方法,如通过从 EP 系统中提取数据进行回顾性评估,9 篇采用了定性方法,如访谈,另有 15 篇采用了混合方法。根据 MMAT,54 项研究中有 32 项被认为是高质量的。根据纳入研究的结果,得出了可能影响处方过程中药物相关决策的三个关键 EP 系统因素:(1)EP 系统中 CDSS 的设计特征(EP 系统的设计如何在处方时与处方者互动,以及使用了哪些设计特征);(2)处方时显示的信息(处方时向处方者显示哪些数据以及如何显示数据);(3)基于系统开发者的 EP 系统类型(商业 EP 系统与自制 EP 系统)。 共发现 18 个 EP 系统因素对处方者的决策和处方工作流程有积极或消极的影响。EP 系统的最终用户对系统的接受度及其在实际工作中的成功发挥了至关重要的作用。然而,在设计、实施和评估 EP 系统的文献中,还需要就如何以及何时评估系统内的任何新修改达成更多共识。未来的研究应探索对处方决策产生积极影响的不同设计策略,并从那些不成功的设计策略中吸取经验教训,以制定 EP 系统设计指南/标准。 1.Samadbeik, M., M. Ahmadi, and S.M. Hosseini Asanjan, A theoretical approach to electronic prescription system: lesson learned from literature review.Iran Red Crescent Med J, 2013.15(10): p. e8436. 2.Sweidan, M., et al., Identification of features of electronic prescribing systems to support quality and safety in primary care using a modified Delphi process.BMC Med Inform Decis Mak, 2010.10: p. 21. 3.Hong, Q.N., et al., The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers.信息教育,2018.34(4): p. 285-291.
期刊介绍:
The International Journal of Pharmacy Practice (IJPP) is a Medline-indexed, peer reviewed, international journal. It is one of the leading journals publishing health services research in the context of pharmacy, pharmaceutical care, medicines and medicines management. Regular sections in the journal include, editorials, literature reviews, original research, personal opinion and short communications. Topics covered include: medicines utilisation, medicine management, medicines distribution, supply and administration, pharmaceutical services, professional and patient/lay perspectives, public health (including, e.g. health promotion, needs assessment, health protection) evidence based practice, pharmacy education. Methods include both evaluative and exploratory work including, randomised controlled trials, surveys, epidemiological approaches, case studies, observational studies, and qualitative methods such as interviews and focus groups. Application of methods drawn from other disciplines e.g. psychology, health economics, morbidity are especially welcome as are developments of new methodologies.